A new study provides a powerful way to study infections in environments that closely mimic human organs. The strategy, tested ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...
Learn about brain disease encephalitis, its causes, symptoms, diagnosis, and treatment options. Understand prevention and ...
Gilead Sciences has announced positive topline results from the Phase 3 ARTISTRY-1 trial. The open-label trial evaluated the treatment responses of adults with HIV who ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today reported that it has received approval to Start Phase II Clinical Trial of ...
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child ...
Merck , known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 2 CADENCE study evaluating WINREVAIRtm (sotatercept-csrk) in adults for the ...
Scientific interest in cannabis has accelerated at an unprecedented pace, with 2025 producing more peer-reviewed research ...
Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global ...
PRINCETON, NJ, Nov. 18, 2025 /PRNewswire/ - Medunik USA, a specialty pharmaceutical company, and part of Duchesnay ...
News-Medical.Net on MSN
Medicaid expansion boosts PrEP access for people at risk of HIV diagnosis
Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback